| RS2146210932 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2146211217 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146211234 |
RTEL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS2146213143 |
SYNJ1
|
Health Risk |
Pathogenic |
Early-onset Parkinson disease 20, Developmental and epileptic encephalopathy |
| RS2146213651 |
SYNJ1
|
Health Risk |
Pathogenic |
Early-onset Parkinson disease 20, Developmental and epileptic encephalopathy |
| RS2146215644 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS2146216115 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2146216467 |
IL12RB1
|
Health Risk |
Likely pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS2146217813 |
STXBP2
|
Health Risk |
Pathogenic |
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL |
| RS2146218837 |
NLRP7
|
Health Risk |
Pathogenic |
— |
| RS2146220482 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2146223995 |
PRODH
|
Health Risk |
Pathogenic |
Proline dehydrogenase deficiency, Proline dehydrogenase deficiency |
| RS2146226413 |
STXBP2
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 5, Familial hemophagocytic lymphohistiocytosis 5 |
| RS2146227158 |
TLK2
|
Health Risk |
Pathogenic |
— |
| RS2146228345 |
TLK2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2146234214 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146234527 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146234838 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 |
| RS2146235121 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146235138 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146236249 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146236314 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146236515 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2146237857 |
APP
|
Health Risk |
Likely pathogenic |
Alzheimer disease type 1, Alzheimer disease type 1 |
| RS2146237965 |
APP
|
Health Risk |
Pathogenic |
Alzheimer disease, Alzheimer disease |
| RS2146238910 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146239036 |
SMARCA4
|
Health Risk |
Pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146241760 |
HPS4
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2146247619 |
NSF
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 96, Developmental and epileptic encephalopathy 96 |
| RS2146254238 |
XPNPEP3
|
Health Risk |
Pathogenic |
Nephronophthisis-like nephropathy 1, Nephronophthisis-like nephropathy 1 |
| RS2146259279 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS2146261671 |
NSF
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 96, Developmental and epileptic encephalopathy 96 |
| RS2146264329 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2146264846 |
GNAS
|
Health Risk |
Likely pathogenic |
— |
| RS2146265828 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2146265987 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2146266663 |
NSF
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy 96, Developmental and epileptic encephalopathy 96 |
| RS2146269292 |
TANC2
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autistic features and language delay, with or without seizures |
| RS2146269629 |
BPTF
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies |
| RS2146270332 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146270735 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146270895 |
XPNPEP3
|
Health Risk |
Pathogenic |
Nephronophthisis-like nephropathy 1, Nephronophthisis-like nephropathy 1 |
| RS2146271310 |
GNAS
|
Health Risk |
Pathogenic |
Pseudopseudohypoparathyroidism, Pseudohypoparathyroidism |
| RS2146272015 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2146272908 |
GNAS
|
Health Risk |
Likely pathogenic |
— |
| RS2146274500 |
XPNPEP3
|
Health Risk |
Likely pathogenic |
— |
| RS2146276502 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Intellectual disability |
| RS2146278333 |
GNAS
|
Health Risk |
Likely pathogenic |
— |
| RS2146278555 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type 1B |
| RS2146278813 |
SPINT2
|
Health Risk |
Likely pathogenic |
Congenital secretory sodium diarrhea 3, Congenital secretory sodium diarrhea 3 |
| RS2146278822 |
SPINT2
|
Health Risk |
Likely pathogenic |
Hepatocellular carcinoma, Hepatocellular carcinoma |
| RS2146279050 |
SMARCA4
|
Health Risk |
Likely pathogenic |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS2146279917 |
SPINT2
|
Health Risk |
Likely pathogenic |
— |
| RS2146283488 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146284067 |
CACNA1G
|
Health Risk |
Likely pathogenic |
Spastic ataxia, Spastic ataxia |
| RS2146285582 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Pseudohypoparathyroidism type I A, GNAS-related disorder |
| RS2146285803 |
GNAS
|
Health Risk |
Likely pathogenic |
— |
| RS2146289554 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146290056 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism, Progressive osseous heteroplasia |
| RS2146290960 |
GNAS
|
Health Risk |
Likely pathogenic |
Progressive osseous heteroplasia, Progressive osseous heteroplasia |
| RS2146291027 |
GNAS
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2146292463 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, GNAS-related disorder |
| RS2146292888 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2146297115 |
TIMP3
|
Health Risk |
Likely pathogenic |
— |
| RS2146299968 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Pseudohypoparathyroidism type 1C, Pseudohypoparathyroidism type I A |
| RS2146300173 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2146300427 |
GNAS
|
Health Risk |
Pathogenic |
8 conditions, 8 conditions |
| RS2146300461 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146300587 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2146304851 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudopseudohypoparathyroidism, Pseudopseudohypoparathyroidism |
| RS2146304864 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146305127 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Pseudopseudohypoparathyroidism, Pseudohypoparathyroidism type I A |
| RS2146305299 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146305350 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2146305803 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism, Pseudohypoparathyroidism |
| RS2146305978 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146306279 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS2146306658 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism type I A, Pseudohypoparathyroidism type I A |
| RS2146306727 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2146308296 |
DNAJC5
|
Health Risk |
Pathogenic |
Ceroid lipofuscinosis, neuronal |
| RS2146309254 |
ARSG
|
Health Risk |
Pathogenic |
— |
| RS2146310027 |
IL12RB1
|
Health Risk |
Pathogenic |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS2146314496 |
KANSL1
|
Health Risk |
Likely pathogenic |
Dysplastic corpus callosum, Dysplastic corpus callosum |
| RS2146314563 |
KANSL1
|
Health Risk |
Pathogenic |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |
| RS2146314756 |
KANSL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Koolen-de Vries syndrome, KANSL1-related disorder |
| RS2146315211 |
MN1
|
Health Risk |
Likely pathogenic |
CEBALID syndrome, CEBALID syndrome |
| RS2146321981 |
IDH3B
|
Health Risk |
Likely pathogenic |
— |
| RS2146325401 |
MYH9
|
Health Risk |
Pathogenic |
— |
| RS2146325507 |
MYH9
|
Health Risk |
Pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS2146336447 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2146336516 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2146338937 |
TLK2
|
Health Risk |
Likely pathogenic |
See cases, TLK2-related disorder |
| RS2146340713 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2146342598 |
ICOSLG
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency, Combined immunodeficiency |
| RS2146343691 |
MYH9
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS2146344203 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2146344336 |
MYH9
|
Health Risk |
Pathogenic |
— |
| RS2146345102 |
MYH9
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia |
| RS2146357374 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2146357893 |
KANSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Koolen-de Vries syndrome, Koolen-de Vries syndrome |